The recall notice said that people who take carbinoxamine instead of Zenzedi have a higher risk for accidents or injuries and may have drowsiness, increased eye pressure, urinary obstruction, and thyroid disorder. The recalled lot has the lot number F230169A and an expiration date of June 2025. Azurity added that it has not received any reports of serious injury related to the medication mix-up.
Consumers who have the recalled medication should return it to their pharmacy. Any adverse reactions to the drug should be reported to the U.S. Food and Drug Administration MedWatch Adverse Event Reporting program. Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
News for Health Professionals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.